tradingkey.logo
๎™๊ฒ€์ƒ‰
์‹œ์žฅ
๊ด€์‹ฌ ๋ชฉ๋ก
๋‰ด์Šค
๋ถ„์„
๋„๊ตฌ
์ข…๋ชฉ ์Šคํฌ๋ฆฌ๋„ˆ
๎™ผ
๎˜
English
็นไฝ“ไธญๆ–‡
เน„เธ—เธข
Tiแบฟng viแป‡t
็ฎ€ไฝ“ไธญๆ–‡
Espaรฑol
Portuguรชs
Deutsch
ํ•œ๊ตญ์–ด
๎˜ณ
ๆ—ฅๆœฌ่ชž
tradingkey.logo
๎™๊ฒ€์ƒ‰
๎™
๎˜

NewAmsterdam Pharma Company NV

NAMS
๎˜ญ๊ด€์‹ฌ ๋ชฉ๋ก์— ์ถ”๊ฐ€
27.790USD
-0.670-2.35%
์ข…๊ฐ€ย 07-31 16:00๏ผˆET๏ผ‰์‹œ์„ธ๋Š” 15๋ถ„ ์ง€์—ฐ๋ฉ๋‹ˆ๋‹ค
3.25B์‹œ๊ฐ€์ด์•ก
์†์‹คP/E TTM

NewAmsterdam Pharma Company NV

27.790
-0.670-2.35%
๊ฐœ์š”
๊ธˆ์œต
ํ† ๋ก 
๋ถ„์„
ํšŒ์‚ฌ
์žฌ๋ฌด ์š”์•ฝ์†์ต๊ณ„์‚ฐ์„œ์žฌ๋ฌด์ƒํƒœํ‘œํ˜„๊ธˆ ํ๋ฆ„ํ‘œ

๊ฐœ์š”

๊ธˆ์œต

ํ† ๋ก 

๋ถ„์„

ํšŒ์‚ฌ

์žฌ๋ฌด ์š”์•ฝ์†์ต๊ณ„์‚ฐ์„œ์žฌ๋ฌด์ƒํƒœํ‘œํ˜„๊ธˆ ํ๋ฆ„ํ‘œ

NAMS ์žฌ๋ฌด ๋ฐ์ดํ„ฐ

์Šค๋งˆํŠธํ•œ ํˆฌ์ž์ž๋ฅผ ์œ„ํ•ด ์„ค๊ณ„๋œ ์˜ฌ์ธ์› ๋ฐ์ดํ„ฐ ๋Œ€์‹œ๋ณด๋“œ๋ฅผ ํ†ตํ•ด NewAmsterdam Pharma Company NV์˜ ์žฌ๋ฌด ๋ฐ์ดํ„ฐ๋ฅผ ํ™•์ธํ•˜์„ธ์š”. ๋ณต์žกํ•œ ์žฌ๋ฌด์ œํ‘œ๋ฅผ ์‚ฌ์šฉ์ž ์ •์˜ ๊ฐ€๋Šฅํ•œ ๋ทฐ๋กœ ๊ตฌ์„ฑํ•˜์—ฌ ์žฌ๋ฌด ๋ถ„์„์„ ์ œ๊ณตํ•ฉ๋‹ˆ๋‹ค. ์ตœ์‹  ์—ฐ๊ฐ„ ์žฌ๋ฌด ๋ณด๊ณ ์„œ์— ์ ‘๊ทผํ•˜๊ฑฐ๋‚˜, ์†์ต๊ณ„์‚ฐ์„œ, ์žฌ๋ฌด์ƒํƒœํ‘œ, ํ˜„๊ธˆ ํ๋ฆ„ํ‘œ๋ฅผ ์‚ฌ์šฉํ•˜์—ฌ ๋ถ„๊ธฐ๋ณ„ ์„ฑ๊ณผ๋ฅผ ๋ถ„์„ํ•˜์„ธ์š”. ์‹ค์‹œ๊ฐ„ ์žฌ๋ฌด ์ง€ํ‘œ๋ฅผ ์†๋์—์„œ ํ™•์ธํ•  ์ˆ˜ ์žˆ์–ด ํšŒ์‚ฌ์˜ ์‹œ์žฅ ๊ฑด์ „์„ฑ์„ ์‹œ๊ฐ„์— ๋”ฐ๋ผ ๊ทธ ์–ด๋Š ๋•Œ๋ณด๋‹ค ์‰ฝ๊ฒŒ ๋ชจ๋‹ˆํ„ฐ๋งํ•  ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค.

NewAmsterdam Pharma Company NV ์‹ค์  ๋ฐœํ‘œ์ผ

์ตœ์‹  ์ถœ์‹œ
May 7, 2026
EPS / ์˜ˆ์ƒ
-0.40/-0.49
์ˆ˜์ต / ์˜ˆ์ƒ
3.04M/936.36K
์˜ˆ์ •๋œ ์‹ค์  ๋ฐœํ‘œ ์ผ์ • ๋ณด๊ธฐ >>
์ฃผ๊ธฐ
FY2025 ์žฌ๋ฌด์ œํ‘œ
์ˆ˜์ต(YoY)
22.50M
-50.61%
EPS(YoY)
-1.72
32.78%
์• ๋„๋ฆฌ์ŠคํŠธ ํ‰๊ฐ€
BUY
2026/08/01
๋ถ„๊ธฐ๋ณ„๎˜ฎ
๋ถ„๊ธฐ๋ณ„+์—ฐ๊ฐ„
๋ถ„๊ธฐ๋ณ„
์—ฐ๊ฐ„
YOY
๋นˆ ํ–‰ ์ˆจ๊ธฐ๊ธฐ
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q2
์žฌ๋ฌด ์ง€ํ‘œ
EPS
-16.92%-0.40
32.64%-0.62
-244.40%-0.61
64.44%-0.15
67.92%-0.34
---0.93
69.26%-0.18
11.73%-0.41
-106.13%-1.06
----
---0.57
---0.47
---0.51
----
----
์ˆ˜์ต
2.08%3.04M
-99.75%32.00K
-98.80%348.00K
740.06%19.14M
112.56%2.98M
--12.77M
889.83%29.11M
32.73%2.28M
-83.76%1.40M
----
--2.94M
--1.72M
--8.63M
----
----
์ˆœ์ด์ต
-22.55%-48.44M
18.72%-74.92M
-332.54%-72.00M
55.48%-17.36M
57.85%-39.53M
---92.18M
64.68%-16.65M
-1.87%-39.01M
-123.16%-93.77M
----
---47.13M
---38.29M
---42.02M
----
----
์ˆœ์ด์ต๋ฅ 
-20.05%-1593.45%
-32341.54%-234134.38%
-36083.00%-20691.09%
94.70%-90.70%
80.17%-1327.30%
---721.71%
96.43%-57.18%
23.25%-1711.58%
-1274.48%-6692.86%
----
---1602.62%
---2230.11%
---486.94%
----
----
์ด ์ด์ต๋ฅ 
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
--100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
----
--100.00%
--100.00%
--100.00%
----
----
๋ถ€์ฑ„๋น„์œจ
----
----
----
----
----
----
----
----
----
-34.33%0.02%
----
----
----
--0.03%
----
์†์ต๊ณ„์‚ฐ์„œ๎˜
์ˆ˜์ต
2.08%3.04M
-99.75%32.00K
-98.80%348.00K
740.06%19.14M
112.56%2.98M
--12.77M
889.83%29.11M
32.73%2.28M
-83.76%1.40M
----
--2.94M
--1.72M
--8.63M
----
----
์˜์—… ์ด์ต
15.24%-58.42M
-52.63%-65.98M
-131.03%-55.14M
30.67%-35.63M
-26.26%-68.92M
---43.23M
50.57%-23.87M
-31.79%-51.40M
-41.32%-54.59M
----
---48.28M
---39.00M
---38.63M
----
----
์ˆœ์ด์ต
-22.55%-48.44M
18.72%-74.92M
-332.54%-72.00M
55.48%-17.36M
57.85%-39.53M
---92.18M
64.68%-16.65M
-1.87%-39.01M
-123.16%-93.77M
----
---47.13M
---38.29M
---42.02M
----
----
์žฌ๋ฌด์ƒํƒœํ‘œ๎˜
์œ ๋™์ž์‚ฐ
-19.49%658.04M
-21.74%675.70M
67.25%732.33M
72.86%769.85M
67.54%817.30M
148.97%863.41M
--437.87M
--445.35M
--487.82M
-27.45%346.79M
----
----
----
--477.98M
--227.41M
์œ ๋™ ๋ถ€์ฑ„ ์ด๊ณ„
64.79%67.42M
-19.76%85.79M
41.25%58.27M
-19.41%36.51M
-31.50%40.91M
114.28%106.92M
--41.26M
--45.31M
--59.73M
38.38%49.90M
----
----
----
--36.06M
--27.15M
์ด ์ž์‚ฐ
-10.48%732.64M
-11.03%769.28M
79.06%786.43M
82.48%815.11M
67.55%818.41M
149.10%864.62M
--439.19M
--446.69M
--488.46M
-27.46%347.10M
----
----
----
--478.50M
--228.35M
๋ถ€์ฑ„ ์ด๊ณ„
64.24%67.42M
-19.85%85.85M
-3.27%58.36M
-38.20%36.62M
-46.45%41.05M
82.47%107.12M
--60.33M
--59.25M
--76.66M
21.21%58.70M
----
----
----
--48.43M
--35.04M
์ž๋ณธ ์ด๊ณ„
-14.43%665.22M
-9.78%683.43M
92.17%728.07M
100.93%778.50M
88.77%777.36M
162.66%757.50M
--378.86M
--387.44M
--411.80M
-32.94%288.39M
----
----
----
--430.07M
--193.31M
ํ˜„๊ธˆ ํ๋ฆ„ํ‘œ๎˜
์ˆœ์˜์—…์ด์ต
16.08%-30.60M
-9.06%-40.88M
-162.11%-32.77M
30.21%-37.67M
33.21%-36.47M
---37.48M
73.39%-12.50M
-84.20%-53.98M
-71.36%-54.60M
----
---46.98M
---29.30M
---31.86M
----
----
์ˆœํˆฌ์ž
-503.12%-11.51M
66.00%-21.14M
3441.33%2.51M
-76041.63%-159.14M
841.56%2.85M
---62.18M
-733.33%-75.00K
-4080.00%-209.00K
-5400.00%-385.00K
----
---9.00K
---5.00K
---7.00K
----
----
์ˆœ์žฌ๋ฌดํ™œ๋™
69.73%11.06M
-97.00%13.68M
10058.62%5.89M
-26.47%3.42M
-96.71%6.52M
--456.61M
-68.82%58.00K
-26.46%4.66M
8185.12%198.18M
----
--186.00K
--6.33M
--2.39M
----
----

์ž์ฃผ ๋ฌป๋Š” ์งˆ๋ฌธ

NewAmsterdam Pharma Company NV์˜ ์ด์ˆ˜์ต์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
NewAmsterdam Pharma Company NV์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ๋งค์ถœ์€ 22.50M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 45.56M์ž…๋‹ˆ๋‹ค.

NewAmsterdam Pharma Company NV์˜ ์œ ๋™์ž์‚ฐ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
NewAmsterdam Pharma Company NV์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์œ ๋™์ž์‚ฐ์€ 675.70M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -21.74์ž…๋‹ˆ๋‹ค.

NewAmsterdam Pharma Company NV์˜ ์ด์ž์‚ฐ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
NewAmsterdam Pharma Company NV์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, NewAmsterdam Pharma Company NV์˜ ์ด์ž์‚ฐ์€ 769.28M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -11.03์ž…๋‹ˆ๋‹ค.

NewAmsterdam Pharma Company NV์˜ ์ด๋ถ€์ฑ„๋Š” ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
NewAmsterdam Pharma Company NV์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, NewAmsterdam Pharma Company NV์˜ ์ด๋ถ€์ฑ„๋Š” 85.85M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -19.85์ž…๋‹ˆ๋‹ค.

NewAmsterdam Pharma Company NV์˜ ์ด์ž๋ณธ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
NewAmsterdam Pharma Company NV์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, NewAmsterdam Pharma Company NV์˜ ์ด์ž๋ณธ์€ 683.43M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -9.78์ž…๋‹ˆ๋‹ค.

NewAmsterdam Pharma Company NV์˜ ์ˆœ์˜์—…์†Œ๋“์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
NewAmsterdam Pharma Company NV์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, NewAmsterdam Pharma Company NV์˜ ์ˆœ์˜์—…์†Œ๋“์€ -225.68M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -28.02์ž…๋‹ˆ๋‹ค.

NewAmsterdam Pharma Company NV์˜ ์ˆœํˆฌ์ž๋Š” ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
NewAmsterdam Pharma Company NV์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, NewAmsterdam Pharma Company NV์˜ ์ˆœํˆฌ์ž๋Š” -174.92M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -178.32์ž…๋‹ˆ๋‹ค.

NewAmsterdam Pharma Company NV์˜ ์ˆœ์ž๊ธˆ์กฐ๋‹ฌ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
NewAmsterdam Pharma Company NV์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, NewAmsterdam Pharma Company NV์˜ ์ˆœ์ž๊ธˆ์กฐ๋‹ฌ์€ 29.52M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -95.52์ž…๋‹ˆ๋‹ค.

NewAmsterdam Pharma Company NV์˜ ์ฃผ๋‹น์ˆœ์ด์ต(EPS)์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
NewAmsterdam Pharma Company NV์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ฃผ๋‹น์ˆœ์ด์ต(EPS)์€ -1.72์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 32.78์ž…๋‹ˆ๋‹ค.

NewAmsterdam Pharma Company NV์˜ ์ˆœ์ด์ต์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
NewAmsterdam Pharma Company NV์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ˆœ์ด์ต์€ -203.82M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 15.64์ž…๋‹ˆ๋‹ค.

NewAmsterdam Pharma Company NV์˜ ์ˆœ์ด์ต๋ฅ ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
NewAmsterdam Pharma Company NV์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ˆœ์ด์ต๋ฅ ์€ -905.74์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -70.81์ž…๋‹ˆ๋‹ค.

NewAmsterdam Pharma Company NV์˜ ์ž๊ธฐ์ž๋ณธ์ด์ต๋ฅ (ROE)์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
NewAmsterdam Pharma Company NV์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ž๊ธฐ์ž๋ณธ์ด์ต๋ฅ (ROE)์€ -28.29์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 38.77์ž…๋‹ˆ๋‹ค.

NewAmsterdam Pharma Company NV์˜ ์ด์ž์‚ฐ์ด์ต๋ฅ (ROA)์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
NewAmsterdam Pharma Company NV์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ด์ž์‚ฐ์ด์ต๋ฅ (ROA)์€ -24.95์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 37.44์ž…๋‹ˆ๋‹ค.

NewAmsterdam Pharma Company NV์˜ ์˜์—…์ด์ต์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
NewAmsterdam Pharma Company NV์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์˜์—…์ด์ต์€ -225.68M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -28.02์ž…๋‹ˆ๋‹ค.
tradingkey.logo
์œ„ํ—˜ ๊ฒฝ๊ณ : ์ €ํฌ ์›น์‚ฌ์ดํŠธ์™€ ๋ชจ๋ฐ”์ผ ์•ฑ์€ ํŠน์ • ํˆฌ์ž ์ƒํ’ˆ์— ๋Œ€ํ•œ ์ผ๋ฐ˜์ ์ธ ์ •๋ณด๋งŒ์„ ์ œ๊ณตํ•ฉ๋‹ˆ๋‹ค. Finsights๋Š” ์žฌ์ •์  ์กฐ์–ธ์ด๋‚˜ ํˆฌ์ž ์ƒํ’ˆ์— ๋Œ€ํ•œ ์ถ”์ฒœ์„ ์ œ๊ณตํ•˜์ง€ ์•Š์œผ๋ฉฐ, ์ด๋Ÿฌํ•œ ์ •๋ณด ์ œ๊ณต์ด Finsights๊ฐ€ ๊ธˆ์œต ์กฐ์–ธ์ด๋‚˜ ์ถ”์ฒœ์„ ์ œ๊ณตํ•˜๋Š” ๊ฒƒ์œผ๋กœ ํ•ด์„๋˜์–ด์„œ๋Š” ์•ˆ ๋ฉ๋‹ˆ๋‹ค.
ํˆฌ์ž ์ƒํ’ˆ์€ ํˆฌ์ž ์›๊ธˆ ์†์‹ค์„ ํฌํ•จํ•œ ์ƒ๋‹นํ•œ ํˆฌ์ž ์œ„ํ—˜์— ๋…ธ์ถœ๋˜์–ด ์žˆ์œผ๋ฉฐ, ๋ชจ๋“  ์‚ฌ๋žŒ์—๊ฒŒ ์ ํ•ฉํ•˜์ง€ ์•Š์„ ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค. ํˆฌ์ž ์ƒํ’ˆ์˜ ๊ณผ๊ฑฐ ์„ฑ๊ณผ๋Š” ๋ฏธ๋ž˜ ์„ฑ๊ณผ๋ฅผ ๋ณด์žฅํ•˜์ง€ ์•Š์Šต๋‹ˆ๋‹ค.
Finsights๋Š” ์ œ3์ž ๊ด‘๊ณ ์ฃผ๋‚˜ ์ œํœด์‚ฌ๊ฐ€ ์ €ํฌ ์›น์‚ฌ์ดํŠธ๋‚˜ ๋ชจ๋ฐ”์ผ ์•ฑ ๋˜๋Š” ๊ทธ ์ผ๋ถ€์— ๊ด‘๊ณ ๋ฅผ ๊ฒŒ์žฌํ•˜๊ฑฐ๋‚˜ ์ „๋‹ฌํ•  ์ˆ˜ ์žˆ๋„๋ก ํ—ˆ์šฉํ•  ์ˆ˜ ์žˆ์œผ๋ฉฐ, ์‚ฌ์šฉ์ž๊ฐ€ ๊ด‘๊ณ ์™€ ์ƒํ˜ธ์ž‘์šฉํ•˜๋Š” ๋ฐฉ์‹์— ๋”ฐ๋ผ ์ด๋“ค๋กœ๋ถ€ํ„ฐ ๋ณด์ƒ์„ ๋ฐ›์„ ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค.
ยฉ ์ €์ž‘๊ถŒ: FINSIGHTS MEDIA PTE. LTD. ๋ชจ๋“  ๊ถŒ๋ฆฌ ๋ณด์œ 
์ด์šฉ ์•ฝ๊ด€
๊ฐœ์ธ์ •๋ณด ์ฒ˜๋ฆฌ๋ฐฉ์นจ
์ฟ ํ‚ค ์ •์ฑ